XH-6003

N/A

Report date: 2025/08/27 14:41:54
NME

Base Information

Drug NameXH-6003
Drug Alias NameXH-6003XH6003JRF-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 12 member 2 antagonistsSodium-(potassium)-chloride cotransporter 2 inhibitors
TargetsSolute carrier family 12 member 2Sodium-(potassium)-chloride cotransporter 2
Therapy Area/IndicationsEncephaloceleBrain Edema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Xunhe Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Xunhe Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsEncephaloceleBrain Edema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A